Member Info for Brondby

There is some important information in here!

We really should not be finding out detail like this from a magazine article!

The system is being built for scalability. Web portal orders, results via secure portal.

And this "We have also partnered with Tasso, a company that makes a painless, user-friendly device for collecting blood at home. Patients simply apply it to their upper arm, and it collects a small blood sample—just enough for our test. Then they mail it to the lab for analysis. I have used it several times, and it is remarkably easy. Tasso has already provided their device for more than a million at-home collections, and we see this as a key tool in making early detection more accessible"

So home testing, no need to visit a hospitals.

All sounding good for launch. Just a question over timing.

Sounds like our TR1 holder and recent investor may be present.

https://x.com/GPJersey1/status/1935234205132407010

🚨Cizzle PLC AGM 🚨 Join us on June 30, 2025, 11 AM at Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch St, London, EC3V 0HR.

Meet the team and find out what your company has planned for the year ahead. #CIZ #CizzlePLC  #AGM #Investors #detectearlysavelives

Thanks ThinShins,

There is some much more confident and bullish language in there than we're used to from ciz (scientists tend not to overpromise and caveat heavily).

"We have already secured our first strategic partner in North America and will be expanding globally through additional licensing and collaborations."

"Revolutionary Detection: The CIZ1B biomarker is highly accurate in early-stage lung cancer detection, and could transform traditional diagnostic pathways"

"Expanding Global Reach: Successful licensing across North America and the Caribbean, with further strategic international expansion underway"

Also note this

"CAP and CLIA Accreditation: Through our U.S. partnerships, CLIA-approved laboratories are finalising CAP accreditation."

Could CAP accreditation be what we waiting on before launch? CLIA certification is mandatory for a LDT. CAP approval is voluntary. So adding this seems significant.

No, come back next week Spartac.

Precisely Cliveas!

And if one PI chose to wade in just now for 10k, watch it go up again.

SP is up today.

No institutions or large investors buying. A few £k traded.

Share prices in small caps move on nothing, as I'm sure you are aware.

Incorrect Sandyman.

If that were the case, the rampers and FUD spreaders would not be here.

Microcaps move on thin air. A few thousand can shift the share price. Absolutely posts here can affect the SP.

Greend100,

Spot on in the observation that ciz bio growth here is limited mainly by access to capital.

Proving the test is commercially viable via the launch of the LDT, showing the potential value through the ASCO paper. All part of making this look attractive to big pharma for a quick buy out and more rapid rollout.

Forget the P&D ers looking for 10%. This is a buy and hold at the current meagre market capital.

US is just one market. And ciz is still workng on an LFT style test which opens up the point of care market. Anything on that front blows the bloody doors off.

This week we're attending #LondonLabLive2025 at @ExceLLondon

Come and meet the @CizzlePlc team and learn how we’re transforming early cancer detection🔬

DM us to arrange a meeting.

https://www.terrapinn.com/exhibition/london-lab-live/index.stm

#CIZ #LungCancer #EarlyDetection #SaveLives

So, 7 posts today here from his tradingstar account, and another couple over on advn where he's switched to full on deramp mode, touting a drop to £1-2m market cap (about 0.4p) and a placing yada yada.

Can we conclude that Joey has finally sold up? 🤣

Or can anyone think of any other reason why you'd talk down a share to encourage others to exit before you(😲) thus dropping the price, rather than selling up first while the price is higher and moving on? 🤷‍♂️

I suppose he could have some kind of defensive pessimism thing going on.

One sign of a rise and he'll be leaping back on board in a panic in case he misses out. Imagine the agony of holding for years and then missing out right at the end! (Almost worth a few extra buys just for the lols)

Nothing happening here until ciz bio launch the test. First contract signed, first lab established. Patiently waiting.

Its an LDT so every Lab using the test must validate the test systems performance *in its own lab environment*

The Lab needs to be CLIA accredited, which iGenomeDX is.

But you still need to do the validation of the test in that lab.

Now they will most likely be following operating procedures and standards defined by cizzle. But you still can't bypass that validation step to show they work as expected in that particular lab. That's why its called a Lab Developed Test!

And its needed for every new lab that comes on board.

I'm sure I posted some links to LDT process (possibly years ago now!)

I wouldn't put it in such stark terms, but certainly buying now has risk, which may or may not pay off. But in many ways risk now is lower, as it seems all cards are on the table in full view, except who will invest and at what price.

For those holding, waiting seems the best plan, as there shouldn't be too long to wait.

We know the product itself is already selling, expanding and now has Medicare coverage, so I'm not convinced there will be much overhang.

Why invest in a product at this late stage, and sell for 10%? In many ways, would seem like the ideal time to invest. With sticky hands this could rapidly fly, so you make your choices and roll with it.

Yes, with a product to sell which is fast gaining traction, and Medicare coverage, I would hope there might be some competition for the raise.

Its unfortunate they didn't get the Medicare last year, but then the sp was 6p+ then. I think this still looks very cheap, even before a placing, and good deal for anyone prepared to hold a year or two.

GLA

Ramping it to a whole 50% above IPO price. Shocking!

You really are appropriately named.

I actually came to post this Ciz Bio blog post from Moffat Cancer centre.

https://www.cizzlebio.com/clinical-thought-leadership/moffitt-ciz1b-blood-test-clinical-trial

...we've all being waiting for the price to go lower as there has been no Amati exit RNS. But some keen investors are getting in early. You can feel the buy pressure here each day.

Makes a change from feeling the sell pressure, an afliction of many of my other shares!

Agreed. Only a few sessions left to tax year end. Let them sell up lower.

Apologies if this has been posted already. Not been following the board closely.

Paper is beyond my undersatanding. Published 11th March 2025.

https://rupress.org/jcb/article/224/5/e202409123/277316/Epigenetic-deprogramming-by-disruption-of-CIZ1-RNA

Yes. Many of the trades marked as sells were buys. Looked like sells being matched by buys (higher price paid a couple of mins after the sells for similar amounts around £5k).

I thought maybe someone transferring shares to an ISA? But there is more than £20k ISA allowance there.

Sometimes I over simplify.

But this was 7p until the delay to coverage determination for its TutiviaTM test.

Assuming we get that through, i would hope this is back in double figures

Https://www.lse.co.uk/rns/conclusion-of-strategic-review-change-of-manager-upj9173hfhsq7a3.html